The FinancialContent Network     SocialPicks Community   |   MarketMinute Monitor   |   MarketMinute Market Updates   |   MarketMinute Stock News
SocialPicks
   Sign Up   |   Log In   |   What is SocialPicks?     

 Aastrom Biosciences Inc.  (ASTM) Trade Now »     Rate ASTM  -  Discuss ASTM  -  Add to Watch List         Graphic_subscribe

       Sector: Healthcare  >  Industry: Biotechnology & Drugs
This is a micro-cap stock and may be a target of manipulation. Always do your research!

SocialPicks Sentiment:

** v.s. other stocks 		This Quarter's Sentiment:
All:
79.5%
Top:
100.0%
Rate ASTM:


Home
Analysis & Videos
Quotes
Bull or Bear
Discuss
        

ASTM: Bull or Bear? From:    SocialPicks  |  Blogsphere  |  All

From the Blogosphere

Regenerative Medicine: The Next Frontier for Big Pharma
Mikerun
73%

<>
An article last week at the WSJ Health Blog outlined plans by Pfizer (PFE) to begin putting its billions of dollars in cash to use in the emerging field of regenerative medicine and stem cell therapies. Also, an article on Bloomberg identifies GlaxoSmithKline (GSK), Johnson & Johnson (JNJ), Novartis (NVS), and Roche (RHHBY) as other healthcare giants as active in regenerative medicine through investments and partnerships.

The move by these healthcare mega-caps comes at a time when credit and funding are scarce for the development-stage and early stage companies which need cash and partnershi...
By  Mike Havrilla   (+1.04%  risk: conservative)  11/17/08 Comment


Regenerative Medicine: The Next Frontier for Big Pharma
Mikerun
73%

<>
An article last week at the WSJ Health Blog outlined plans by Pfizer (PFE) to begin putting its billions of dollars in cash to use in the emerging field of regenerative medicine and stem cell therapies. Also, an article on Bloomberg identifies GlaxoSmithKline (GSK), Johnson & Johnson (JNJ), Novartis (NVS), and Roche (RHHBY) as other healthcare giants as active in regenerative medicine through investments and partnerships.

The move by these healthcare mega-caps comes at a time when credit and funding are scarce for the development-stage and early stage companies which need cash and partnershi...
By  Mike Havrilla   (+1.04%  risk: conservative)  11/17/08 Comment


Friday's Upgrades and Downgrades
 2 %
<>
UPGRADES
Popular Inc (BPOP)- B. Riley & Co Neutral » Buy
United Comm Banks (UCBI)- Sterne Agee Sell » Hold
Landstar System (LSTR)- KeyBanc Capital Mkts Hold » Buy
Pike Electric (PEC)- Friedman Billings Mkt Perform » Outperform
Silicon Labs (SLAB)- Friedman Billings Mkt Perform » Outperform
Energy East (EAS)- Jefferies & Co Underperform » Hold
Casella Waste (CWST)- JP Morgan Neutral » Overweight
CarMax (KMX)- Wachovia Underperform » Mkt Perform
American Intl (AIG)- Citigroup Hold » Buy
Sepracor (SEPR)- UBS Neutral » Buy

DOWNGRADES
FedEx (FDX)- B...
By  Todd Sullivan   (-25.49%  risk: aggressive)  06/20/08 Comment


Friday's Upgrades and Downgrades
<>
UPGRADES
Popular Inc (BPOP)- B. Riley & Co Neutral » Buy
United Comm Banks (UCBI)- Sterne Agee Sell » Hold
Landstar System (LSTR)- KeyBanc Capital Mkts Hold » Buy
Pike Electric (PEC)- Friedman Billings Mkt Perform » Outperform
Silicon Labs (SLAB)- Friedman Billings Mkt Perform » Outperform
Energy East (EAS)- Jefferies & Co Underperform » Hold
Casella Waste (CWST)- JP Morgan Neutral » Overweight
CarMax (KMX)- Wachovia Underperform » Mkt Perform
American Intl (AIG)- Citigroup Hold » Buy
Sepracor (SEPR)- UBS Neutral » Buy

DOWNGRADES
FedEx (FDX)- B...
By  Todd Sullivan   (+0.00%)  06/20/08 Comment



ROCK-STAR INVESTORS
Rank Name Sharpe Ratio Avg Return Followers
1 noshoes 21.10 +34.25% 381
2 Gerald Greene 18.14 +72.34% 210
3 stockmarketfunding.com 17.66 +25.65% 55
4 akiralegrand 13.47 +14.32% 62
5 anup2104 12.13 +76.91% 39


POPULAR STOCKS
Symbol Company Name Sentiment
GE General Electric Company
JNJ Johnson & Johnson
SBUX Starbucks Corp
LEH Lehman Brothers Holdings Inc
AIG American International Group Inc.
INTC Intel Corp

TODAY'S HEADLINES

TODAY'S TOP PICKS

 

StreetInsider.com on ASTM

Visit streetinsider.com


Discussion Wall + Add  
amritadas   (+0.00%)
Upcoming FDA decision on the approval of a new Gout.. - An upcoming treatment by a small cap company for Gout to face FDA decision on approval shortly. Gout has traditionally been a difficult disease to tre
+   0 replies

amritadas   (+0.00%)
A FREE report on the approval of a new Gout Drug - FDA Panel to review this Biotech company's stress agent drug on July 28th. If they get a favorable backing by the panel, the chances of approval by th...
+   0 replies

amritadas   (+0.00%)
Free report on upcoming FDA panel decision of Corvu.. - FDA Panel to review this Biotech company's stress agent drug on July 28th. If they get a favorable backing by the panel, the chances of approval by th...
+   0 replies


More Resources

Graphic_arrow1 About Aastrom Biosciences Inc. - Answers.com

Graphic_arrow1 Historical Prices - Yahoo

Graphic_arrow1 Message Boards - BoardCentral.com

Graphic_arrow1 More Info:     Yahoo   |   Google   |   Reuters




IN THE PRESS
Press_forbes Press_washingtonpost Press_wsj Press_npr Press_techcrunch